Sell Your Veterinary Practice in Georgia in 2026: 5-13x by Tier, PE Platforms, CPVM Structure

Selling your veterinary practice in Georgia in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty scale. Atlanta and Savannah density supports platform-quality deals, plus Georgia’s flat 4.99% income tax for 2026 shapes after-tax proceeds. Active Georgia buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland.

Georgia sits in the busiest corner of the Sun Belt for animal-health consolidation, and that shapes what your practice is worth. American Economic Liberties Project figures put cumulative private-equity investment in US veterinary at $51.6 billion across 2017 to 2023, with another $9.3 billion in the first four months of 2024 alone. What gives a Georgia owner a strong seat at that table is a single very large metro: the Atlanta MSA holds roughly 6.3 million people (US Census Bureau), one of the biggest in the country, and Mars Veterinary Health already runs a cluster of Banfield and VCA hospitals across it. That concentration means a clean, multi-doctor Atlanta practice is rarely negotiating against one bidder.

This guide is written for the Georgia DVM who wants to know the price and the path. It walks through 2026 multiples by EBITDA tier, the wellness-plan premium that moves general-practice value most, the named consolidators with clinics already on Georgia ground, and the parts of a Georgia deal that differ from the national template: the Georgia State Board of Veterinary Medicine premise permit, the fact that Georgia expressly permits a veterinarian to practice as an employee of a corporation under O.C.G.A. 43-50-30(c) rather than banning corporate ownership, the Georgia Restrictive Covenants Act that governs whether your non-competes hold, and the Georgia tax picture that decides how much of the check you keep.

CT Acquisitions runs confidential, buy-side processes. We are not a business broker, the buyer pays our fee, and a seller pays no commission, no retainer, and signs no exclusivity contract. For wider context, see our veterinary hub guide, our Private Equity in Veterinary 2026 report, our national guide to selling a veterinary practice, our specialty hospital guide, and our 36-month veterinary practice exit playbook. The free valuation survey takes about three minutes.

How Georgia veterinary practices are valued in 2026, the tiered framework

Georgia veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally but read against an unusually deep Atlanta bidder pool. A one-DVM lifestyle or rural mixed-animal clinic sits below the threshold where corporate diligence pays for itself, so it usually changes hands between DVMs rather than going to a platform. Move up the tiers and the Atlanta buyers start bidding.

Georgia veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally but read against an unusually deep Atlanta bidder pool. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where corporate diligence pays for itself and typically clears 5x to 7x, changing hands between DVMs or small regional groups rather than going to a platform. A two-to-three-DVM general practice at $500K to $1M of adjusted EBITDA lands in the 7x to 9.5x range, with the top of that band earned by high-margin books that do not lean on one doctor. The four-to-eight-DVM hospital at $1M to $3M is where the Atlanta platforms compete hardest and clears 9.5x to 11.5x, reaching 12x when the books are clean and a second-tier doctor bench is in place. Above $3M, usually a multi-doctor specialty or referral group, pricing runs 11x to 13x and can stretch to 16x to 18x for a marquee specialty hospital an aggregator wants for geographic fill. Specialty, emergency and 24/7 hospitals carry a 1.5x to 3x premium over general practice. R.L. Hulett’s Q1 2025 Pet M&A Update reported closed transactions spanning 6x to 16x adjusted EBITDA, and per the American Economic Liberties Project private-equity buyers supplied roughly 80% of 2024 veterinary deal capital. A wellness-plan book above 15% of eligible general-practice cases routinely adds 0.5x to 1.5x on top of the size-tier baseline.

Georgia practice profile	Typical multiple	What moves it in Georgia
Single-DVM lifestyle / rural mixed-animal under $500K EBITDA	5-7x EBITDA	Below the platform diligence floor; sells DVM-to-DVM, common across south Georgia and the rural coastal plain
2-3 DVM general practice ($500K-$1M EBITDA)	7-9.5x EBITDA	Draws real bidders inside metro Atlanta even at modest scale, because buyers already run local clusters
4-8 DVM hospital ($1M-$3M EBITDA)	9.5-11.5x EBITDA (clean books to 12x)	The tier the Atlanta platforms compete for; associate bench and wellness penetration decide the top end
$3M+ EBITDA multi-doctor / specialty / referral	11-13x EBITDA (16-18x for marquee specialty)	Atlanta’s size and affluence support specialty demand; referral catchment carries it
Multi-site groups (3+ hospitals)	12-15x EBITDA	Metro-Atlanta density commands platform-of-platform pricing

The lever that separates a floor multiple from an Atlanta multiple is competition. A four-doctor Georgia hospital with $1.5M of EBITDA taken quietly to one strategic buyer might settle at 9.5x to 10.5x, roughly $14M to $16M. Placed into a competitive process across the platforms that already operate in metro Atlanta, that same hospital pulls a second and third bidder to the table, and buyers who mark tuck-ins up on their own balance sheet will pay one to two turns more to win the geography.

The wellness-plan / membership premium, the single biggest GP valuation lever

For a Georgia general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Recurring monthly membership revenue turns transactional cash flow into something a buyer can underwrite as predictable, and every Atlanta consolidator now expects it.

For a Georgia general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Practice-management software vendors put plan penetration above 18% of eligible patients across the US, and members spend two to three times what non-plan clients do, so a healthy book converts transactional cash flow into monthly recurring revenue that buyers value more highly because it smooths seasonality, signals retention, and supports a defensible lifetime-value calculation after close. Banfield built the model at scale with its Optimum Wellness Plans, and the groups buying in Georgia, from Mars and GoodVets to VetCor and Alliance Animal Health, expect an acquired hospital to be on a branded plan within a year to eighteen months. The way to capture the premium in a Georgia process is to stand the plan up 18 to 24 months before you go to market, push penetration past 12 to 15% of eligible general-practice cases, break the recurring revenue out as its own line in the financial pack, and carry it into the quality-of-earnings report as a distinct book. Georgia hospitals that arrive at market with more than 20% penetration and average member tenure past two years regularly clear 75 to 150 basis points above their size-tier baseline. The mirror image is the risk: a purely transactional Georgia practice with thin repeat visits gets marked down in the same diligence.

Earnouts, DVM retention, and what Georgia platform buyers underwrite

In Georgia deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention, not patient demand, so the structure leans on the seller and the associate bench staying put. The Atlanta buyers pay strong cash at close but hold a slice against clinical continuity.

In Georgia deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention rather than patient demand, so the structure leans on the seller and the associate bench staying put. A typical Georgia two-to-eight-DVM hospital sold to a platform closes on roughly 70 to 80% cash, with 10 to 20% rolled into equity in a Newco or a platform-level holding company and 5 to 15% held as an earnout keyed to the selling doctor’s clinical hours through years one to three, associate retention through years one to two, and trailing-twelve EBITDA holding its baseline. Above $5M of enterprise value the rollover slice usually rises to 20 to 30%. The recurring fight is production-comp normalization: many Georgia owners run associate pay at 20 to 25% of production plus distributions, while platforms reset associates to 22 to 24% straight production with no profit share and then recompute adjusted EBITDA on that basis, so agreeing a ProSal floor with the buyer six to twelve months before signing heads off the haircut. The clawbacks have teeth: a typical structure fires if the selling DVM drops under 32 hours a week or under 80% of historical production for any 60-day window in the earnout period, and an associate departure inside 18 months releases part of the escrow back to the buyer. Relief-doctor hours through IndeVets, Roo and similar staffing services generally do not count toward the production thresholds, which matters in metro Atlanta where relief coverage is easier to lean on than in the rural south.

Platform-versus-tuck-in arbitrage, the 5-7 turn multiple expansion

The gap between what a platform pays for a single Georgia hospital and what that hospital is worth once it sits inside a larger group is the reason the buyers keep coming back to Atlanta. That spread is where the premium a seller can capture actually lives.

The gap between what a platform pays for a single Georgia hospital and what that hospital is worth once it sits inside a larger group is the reason the buyers keep coming back to Atlanta. A standalone four-doctor Georgia general practice at $1.5M of EBITDA sold direct might clear 9.5x to 10.5x. Tucked into a group that itself trades at a 15x to 18x platform multiple, the same earnings get re-marked at five to seven turns higher on the acquirer’s books, which is why groups such as VetCor, Alliance Animal Health and GoodVets will pay 11x to 12x for a $1M to $2M Georgia hospital they want. The catch for a Georgia seller is that the premium only shows up when the buyer actually wants your geography or species mix. An off-thesis hospital, wrong corner of the state, wrong case load, or soft earnings quality, gets the floor multiple regardless of how many platforms exist. That is where metro Atlanta helps: because several buyers already operate clusters across the metro, an Atlanta-area owner who runs four to six of them in parallel is far more likely to find the one for whom the practice is on-thesis, and to convert that into one or two extra turns. Tighter acquisition-debt markets through 2024 and 2025 trimmed platform multiples by a turn or two from the 2021 to 2022 peak, and the late-2025 rate cuts have restarted committed financing, which is part of why Georgia buyers are active again in 2026.

Who is buying Georgia veterinary practices in 2024-2026, named platforms with CURRENT ownership

The Georgia buyer pool is the national buyer pool with several of its members already on the ground in metro Atlanta. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives, with Mars and GoodVets the confirmed Atlanta presences.

The Georgia buyer pool is the national buyer pool with several of its members already operating inside metro Atlanta. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives. Mars Veterinary Health is the largest, folding VCA, Banfield and the BluePearl specialty and emergency network under one strategic, permanent-capital umbrella rather than a fund, and per the CT Acquisitions Georgia buyer ledger it runs Banfield hospitals in Buckhead, Midtown and Castlegate plus VCA Buckhead, VCA Midtown and VCA North Atlanta in Sandy Springs. GoodVets, the Chicago-founded co-ownership model that partners with local DVMs, operates in Atlanta per the same ledger. NVA sits under JAB Holding Company with its Ethos specialty and emergency division, and the 2022 FTC consent order from the SAGE deal still restricts JAB specialty and ER acquisitions within 25 miles of an existing JAB clinic in California and Texas. Mission Pet Health, backed by Shore Capital Partners, reached roughly 750 clinics after the July 2025 merger of Mission Veterinary Partners and Southern Veterinary Partners, a group whose roots are in the Southeast. VetCor is led by Oak Hill Capital with Harvest Partners and Cressey & Co. and has been among the most active general-practice tuck-in buyers. PetVet Care Centers has been owned by KKR since 2022 (not Onex). Heartland Veterinary Partners is now Gryphon Investors majority after its 2024 to 2025 recap (not American Securities); AmeriVet is held by AEA Investors and the Abu Dhabi Investment Authority since the February 2022 recap (not Imperial Capital) and operates under the Alliance Animal Health banner. Other national platforms in the pool include Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus, urgent care), VetEvolve (Varsity Healthcare) and Thrive Pet Healthcare (TSG Consumer), most of which acquire across all 50 states even where the ledger has not yet confirmed a named Georgia location. The doctor-controlled route is real in Georgia too: MedVet is roughly 95% DVM and employee owned with a Leonard Green minority, and Galaxy Vets is the first US consolidator built as an employee stock ownership plan.

Veterinary sub-verticals and how each is valued

Buyers rank Georgia veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis; specialty and referral sit at the top of the multiple range, and metro Atlanta’s size gives Georgia solid specialty demand.

Buyers rank Georgia veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis at 5x to 12x adjusted EBITDA by size, with buyers favoring two-to-eight-DVM hospitals that carry a stable associate bench, own or control their real estate, and run a wellness book. Specialty and referral practices, covering surgery, internal medicine, oncology, cardiology, neurology, dermatology and ophthalmology, trade highest at 11x to 14x and up to 16x to 18x for a marquee multi-specialist hospital with strong referral catchment. Georgia is reasonably well served here because metro Atlanta is large and affluent enough to support referral specialty volume and Mars BluePearl competes for those cases, so an Atlanta specialty seller faces real bidding rather than a thin market. Emergency, urgent-care and 24/7 hospitals carry 11x to 13x on the scarcity of overnight staffing and the specialty cross-sell. Mixed-animal, equine and food-animal practices, more common in south and middle Georgia, are a separate buyer pool at 5x to 8x, since production-animal economics, travel logistics and USDA APHIS oversight do not standardize well at platform level and the buyers tend to be other large-animal DVMs or regional groups. Mobile and house-call practices are capital-light but doctor-time-bound with little platform appetite because there is no real-estate moat. Multi-site groups of three or more hospitals are the single most attractive Georgia archetype, since metro Atlanta gives buyers regional density and a pipeline of further tuck-ins, and they pay platform-of-platform multiples of 12x to 15x for it.

Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.

Georgia veterinary market context

Georgia permits corporate ownership of a veterinary practice rather than banning it, and metro Atlanta, at roughly 6.3 million people, is the deepest single vet market in the Southeast. Platform activity concentrates heavily in Atlanta, with the University of Georgia vet school in Athens feeding the associate pipeline.

Georgia permits corporate ownership of a veterinary practice rather than banning it, which is the first thing that separates it from restricted states like New York or Texas. O.C.G.A. 43-50-30(c) expressly allows a licensed veterinarian to practice as an employee of a corporation, partnership or other business organization, as long as the veterinarian is not subject to the direction of a non-licensee in making veterinary medical decisions, so a corporate buyer can hold a Georgia practice directly and most deals proceed without the friendly-PC-plus-management-company scaffolding that restricted states require. Demand concentrates where the people and the doctors are. Metro Atlanta, at roughly 6.3 million people (US Census Bureau), is one of the largest metros in the country and anchors the deepest specialty and general-practice market in the state, while Savannah, Augusta, Columbus and Macon are far smaller one-to-two-bidder markets. The University of Georgia College of Veterinary Medicine in Athens, a top-ten national program roughly 70 miles from Atlanta whose class was expanded to 150 seats, feeds an in-state associate pipeline that lowers the staffing risk buyers weigh most heavily near the metro and along the Athens corridor. Atlanta is a fast-growth Sun Belt market with corporate-HQ affluence, so buyers price the metro far more aggressively than the rural south, where incomes are lower and growth is flat to declining.

Which buyers are actually near your Georgia practice, and what your location does to your negotiating position

One deep, fast-growing buyer market in metro Atlanta; a sharp drop to thin mid-metros and a platform-scarce rural south.

• GoodVets: Atlanta
• Mars Veterinary Health (Banfield / VCA): Atlanta (Banfield Buckhead, Midtown, Castlegate, all in-PetSmart); VCA Buckhead, VCA Midtown, VCA North Atlanta / Sandy Springs

Your location scored on five factors

Proximity to an existing platform is the hook, but it only converts if you clear the size bar, and three more factors, metro depth, DVM labor supply, and the demand trend, decide how hard buyers actually compete. Here is how Georgia reads on all five.

Factor	What it means for your exit
Buyers near you	Metro Atlanta (x-large) hosts a confirmed multi-buyer bench, Mars (Banfield + VCA, multiple named hospitals) and GoodVets, plus the near-certain (unconfirmed) presence of the other 40-state consolidators. Athens (UGA) and Macon sit inside Atlanta’s ~2-hour reach; Savannah, Augusta, and the rural south are isolated, platform-thin micro-markets.
Your size gate	In metro Atlanta the bar is LOW, a buyer can absorb even a solid solo practice as a metro tuck-in; the farther out (Savannah/Augusta/Columbus, then rural south) the higher the practical floor, because an isolated site must be stood up as a supported unit. Sliding scale, expressed relatively (no defensible single EBITDA figure).
Metro depth	Atlanta (~6.3M) anchors a deep, genuine multi-bidder bench; Savannah (~432K), Augusta (~600K incl. SC), Columbus (~330K incl. AL), and Macon (~235K) are mid-to-small one-to-two-bidder markets; rural south Georgia is micro/absent.
DVM labor supply	UGA’s College of Veterinary Medicine (No. 7 nationally, class expanded to 150), ~70 miles from Atlanta, is a strong in-state pipeline that lowers staffing risk across metro Atlanta and the Athens corridor; that advantage attenuates sharply toward the coast and rural south.
Demand trend	Metro Atlanta is a fast-growth Sun Belt market (~+75K/1.2% in 2023-24, in-migration-led, HQ-anchored affluence) driving durable premium wellness demand; rural south Georgia is lower-income and flat-to-declining. (Watch: Atlanta’s domestic net migration turned slightly negative in 2024, offset by international.)

If your practice is in metro Atlanta, you are in the strongest single market in the Southeast for a vet exit: Mars runs multiple Banfield and VCA hospitals across the metro, GoodVets is present and expanding, and the other national 40-state consolidators almost certainly operate here too, so a clean, multi-doctor Atlanta practice can realistically draw several credible bidders. But proximity is gated by your scale. In metro Atlanta that gate is low, buyers already have local clusters, so even a solid solo or two-doctor practice can be absorbed as a tuck-in with little marginal overhead. Outside Atlanta the gate rises with distance. Savannah, Augusta, and Columbus are their own isolated mid-metro markets, and rural south Georgia is farther still, three to four hours from any hub, lower-income, and harder to staff, so a sub-scale practice there will not pull institutional attention and is more likely to sell to a local individual or regional buyer.

MSA depth backs the Atlanta story. At ~6.3M it is one of the largest metros in the country and its 2-hour reach pulls in Athens and Macon, so a platform can cluster practices and share specialty, ER, and relief coverage, real synergy that supports a competitive multiple. The mid-metros and rural south are thin one-to-two-bidder markets. Labor is a genuine tailwind in and around Atlanta: the University of Georgia runs a top-ten national vet school in Athens, only ~70 miles away, and it just expanded its class to 150, so associate availability, a buyer’s biggest worry once the founder slows down, is materially de-risked in the metro. That advantage does not travel to the coast or the rural south. Demand is a tailwind too: Atlanta is a fast-growth Sun Belt market with corporate-HQ affluence, though its domestic net migration has cooled and growth is now increasingly immigration-led, a nuance, not a reversal.

Georgia’s legal backdrop is broadly buyer- and deal-friendly, which helps a clean process. Non-DVM ownership is permitted (a DVM must keep clinical control), so the platform model runs freely. The Restrictive Covenants Act makes Georgia a relatively employer-friendly non-compete state: courts will blue-pencil an overbroad covenant down rather than void it, a sale-of-business non-compete of up to about five years is presumptively reasonable, and, unlike associate-mobility states such as Colorado, buyers can keep enforceable, geographically-limited associate non-competes, so doctor retention is more defensible contractually (any covenant still needs a real territory to survive). The income tax is flat and falling, 5.19% for 2025 under HB 111, trending toward 4.99%, and it hits your gain as ordinary income with no preferential rate, a modestly seller-favorable and improving backdrop. Net: metro Atlanta combines strong proximity, a low size gate, a deep MSA, a top-ten labor pipeline, a growth tailwind, and an employer-friendly legal regime, one of the more seller-friendly vet markets in the Sun Belt; Savannah, Augusta, Columbus, Macon, and especially the rural south are progressively thinner scarcity plays that reward a genuinely differentiated practice and punish a sub-scale one.

State CPVM framework, premise permits, and FTC scrutiny for a Georgia sale

Selling a Georgia veterinary practice touches three regulatory layers, but the first one is friendlier here than the national template assumes: Georgia does not bar non-veterinarian ownership. The layers are the Georgia State Board of Veterinary Medicine premise permit, federal DEA registration, and the antitrust backdrop.

Selling a Georgia veterinary practice touches three regulatory layers, and the first is friendlier here than the national template assumes. Many states restrict or prohibit non-veterinarian ownership and force private-equity buyers into a management-services-organization structure where a friendly DVM holds the practice while a company owned by the sponsor provides administration under a long-term services agreement. Georgia is not one of those states. O.C.G.A. 43-50-30(c) expressly permits a licensed veterinarian to practice as an employee of a corporation, partnership or other business organization, provided no non-licensee directs the vet’s medical judgment, so a corporate or PE buyer can own the Georgia practice entity directly. That means most Georgia buyers can hold the practice without the friendly-PC arrangement and can usually avoid the $50K to $150K of extra structuring cost that a restricted-state workaround adds. What Georgia does require is attention to the facility credential: a practice operates under a premise permit issued by the Georgia State Board of Veterinary Medicine, and the permit and the designated veterinarian records need to be kept current through an ownership change, so the permit update belongs on the closing checklist. The second layer is federal and unchanged by state law: each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture. The 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda, so a deal where the likely Georgia buyer already owns nearby specialty or ER capacity can draw a longer review.

How this applies to a Georgia veterinary practice sale

For a Georgia seller the sequence is shorter than in a restricted state. First, ownership: because O.C.G.A. 43-50-30(c) allows a vet to be employed by a corporation, the deal usually does not need a friendly-PC-plus-management-company workaround, which removes a cost and a delay that New York, Texas or Illinois sellers cannot avoid, so long as the employed Georgia-licensed veterinarian keeps independent control of all medical decisions. Second, the premise permit: the practice keeps its Georgia State Board of Veterinary Medicine premise permit and designated-veterinarian records current and files the ownership change with the board. Third, DEA: the new owner secures a fresh DEA registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222, with the Georgia Board of Pharmacy facility credential updated in parallel. Fourth, antitrust: if the most likely platform bidder already holds specialty or emergency capacity near you, in the Atlanta clusters especially, build extra review time into the calendar. Plan on roughly 90 to 150 days from signing to close, with the DEA reissuance and, in specialty-dense pockets, any FTC look as the constraints that actually set the pace.

Deal mechanics specific to Georgia veterinary practice sales

The deal mechanics on a Georgia veterinary sale follow the national pattern with two Georgia-specific bends: non-compete enforceability runs on the Georgia Restrictive Covenants Act, which lets courts blue-pencil an overbroad covenant, and the ownership-transfer step is a premise-permit update rather than a corporate-practice workaround.

The deal mechanics on a Georgia veterinary sale follow the national pattern with a couple of Georgia-specific bends. Rollover equity typically runs 20 to 30% of proceeds into a Newco or platform holding company on deals above $5M of enterprise value, vesting over three to five years and monetizing at the next recap on a four-to-six-year hold. The DVM-retention earnout holds 5 to 15% of consideration against the seller’s continued clinical hours, associate retention through years one to two, and EBITDA stability, with a clawback if the seller falls under 32 hours a week or under 80% of pre-close production for any 60-day window. Production-comp normalization is the same recut buyers apply everywhere: associates reset to 22 to 24% straight production and adjusted EBITDA is recomputed on that basis, which can trim it 5 to 15% unless the seller pre-empts it. The first Georgia-specific point is non-competes. Georgia’s Restrictive Covenants Act (O.C.G.A. 13-8-50 et seq.) makes the state relatively employer-friendly: a court may blue-pencil an overbroad covenant down rather than void it, a sale-of-business non-compete running up to about five years is presumptively reasonable, and, unlike associate-mobility states such as Colorado, Georgia buyers can keep enforceable, geographically-limited associate non-competes, so doctor retention is more defensible contractually, provided any covenant still names a real territory. The second Georgia-specific point is the ownership transfer itself: instead of restructuring around a corporate-practice ban, the parties keep the Georgia State Board of Veterinary Medicine premise permit and designated-veterinarian records current and file the change with the board. Real estate is commonly split into a separate entity at signing and leased back on a 15-to-20-year triple-net lease, leaving veterinary real estate as independent optionality at roughly 5.5% to 7.5% cap rates.

The DVM succession crisis, why Georgia owners are selling now

The engine behind the Georgia selling wave is succession, not a doctor shortage. The AAVMC projects enough new graduates to meet aggregate demand, so the real driver is an aging pool of practice owners deciding to step back, and Georgia has a large cohort reaching that decision now.

The engine behind the Georgia selling wave is succession, not a doctor shortage. The 2025 AVMA Report on the Economic State of the Veterinary Profession counts roughly 130,415 DVMs in the US workforce, most in small-animal practice, and the AAVMC 2024 supply-and-demand study concluded that new graduates from existing colleges should meet aggregate demand through the mid-2030s, with real shortfalls concentrated in rural, food-animal and emergency staffing rather than across the board. The more durable driver is demographic. Peer-reviewed survey work published in JAVMA over 2024 and 2025 found that 61% of clinical-practice DVMs intend to cut clinical hours within five years and 31% intend to stop clinical work entirely, and roughly 8% of working veterinarians are already 66 or older. Georgia feels this on two sides at once: its metro practices sit near a steady University of Georgia graduate pipeline that keeps associate supply healthier than in thinner states, while its large base of owner-operators who built practices in the 1980s and 1990s is now reaching retirement. With private-equity capital restarted by the late-2025 rate cuts and buyers already positioned across metro Atlanta, 2026 through 2030 is the structural window when more Georgia owners cross 60 than at any prior point.

Why a Georgia veterinary practice sale needs vertical-specific advice

A generalist advisor who treats a Georgia veterinary practice as any other services business will miss the levers that move the price and will misread the Georgia rules, most importantly by assuming a corporate-practice ban that Georgia does not have.

A generalist advisor who treats a Georgia veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between enforceable sale-of-business non-competes and more contestable associate covenants are all veterinary-specific diligence items. Two of them are Georgia-specific. The first is that Georgia permits corporate ownership under O.C.G.A. 43-50-30(c), so an advisor who reflexively builds a friendly-PC-plus-management-company structure adds cost and delay the deal does not need. The second is that Georgia non-competes turn on the Restrictive Covenants Act and its blue-pencil rule rather than a bright-line ban, which changes how you draft and how you value doctor retention. A Georgia seller working with someone who knows the current platform cap tables, which buyers already sit in metro Atlanta, and how Georgia actually permits and enforces, negotiates as an equal rather than being educated by the buyer’s diligence team at their own expense.

The 18-24 month pre-sale playbook for Georgia veterinary practices

Georgia owners who reach the top of their tier prepare deliberately over 12 to 24 months. The priorities are the wellness book, a real associate bench, clean normalized earnings, a current premise permit, and using metro Atlanta to run a genuine competitive process.

Georgia owners who reach the top of their tier almost always prepared deliberately. With 12 to 24 months of runway, work down this list:

• Stand up a wellness plan 18 to 24 months out. Push penetration past 12 to 15% of eligible cases, break recurring revenue out in the financials, and carry it into the quality-of-earnings report; in a Georgia process this one move can add 75 to 150 basis points over the size-tier baseline.
• Move associates to ProSal six to twelve months before signing. Pre-empting the platform production-comp reset neutralizes the 5 to 15% EBITDA haircut buyers otherwise apply.
• Build the associate bench. A single-DVM practice sits below the platform floor; getting to two or three doctors reaches 7x to 9.5x and four to eight reaches the 9.5x to 11.5x tier, and near Atlanta the University of Georgia pipeline makes hiring that bench realistic.
• Normalize owner compensation. Set owner W-2 and production at market and let the excess fall to EBITDA, documented in payroll and K-1 detail before diligence starts.
• Keep the premise permit and DEA clean. A current Georgia State Board of Veterinary Medicine premise permit, an up-to-date designated veterinarian on record, and an accurate Schedule II inventory are table stakes in Georgia diligence.
• Draft non-competes to the Restrictive Covenants Act. A reasonable territory and term that protect a legitimate interest are far more likely to survive a Georgia court, which can blue-pencil an overbroad covenant, and they reassure the buyer on doctor retention.
• Decide on the real estate. Carving the building into a separate entity and leasing it back on a long triple-net at market rent creates independent optionality at roughly 5.5% to 7.5% cap rates.
• Use metro Atlanta. Because several platforms already operate clusters across the metro, run four to six of them in parallel rather than taking the first inbound offer; competition is what converts proximity into price.

For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.

Common mistakes Georgia veterinary practice owners make when selling

The mistakes that cost Georgia sellers money cluster around anchoring on revenue, missing the production-comp recut, chasing outdated buyer lists, and taking the first offer when metro Atlanta gives them a real auction.

• Anchoring on revenue instead of adjusted EBITDA, doctor-retention structure and wellness-plan penetration, which are what buyers actually pay for.
• Not modeling the production-comp recut. Platforms reset associates to 22 to 24% straight production and recompute EBITDA, a 5 to 15% cut that is routine unless you pre-empt it.
• Working an outdated buyer list. PetVet is KKR (not Onex), Heartland is Gryphon (not American Securities), AmeriVet is AEA and ADIA (not Imperial Capital), United Veterinary Care is Nordic Capital (not Atlantic Street), and Suveto is Levine Leichtman (not LongueVue); outreach to stale cap tables wastes runway.
• Assuming Georgia bans corporate ownership. It does not; O.C.G.A. 43-50-30(c) allows a vet to be employed by a corporation, so building a friendly-PC-plus-management-company structure the deal does not need adds cost and delay rather than protection.
• Drafting non-competes that ignore the Restrictive Covenants Act. A reasonable covenant with a real territory holds up and a Georgia court can narrow an overbroad one, but a vague covenant invites a challenge.
• Overlooking the doctor-controlled route. MedVet, roughly 95% DVM and employee owned, and Galaxy Vets, built as an ESOP, are genuine Georgia-accessible options for owners who want liquidity without handing clinical control to a fund.
• Taking the first inbound offer. With multiple platforms clustered across metro Atlanta, a confidential competitive process typically lifts terms by one to two turns of EBITDA over a single-bidder negotiation.

Sell Your Veterinary Practice: Georgia and beyond

Companion guides for Georgia sellers:

• Sell Your Veterinary Practice / Animal Hospital (national overview)
• Private Equity in Veterinary 2026: Active Platforms, Multiples, and Consolidation
• How to Sell a Veterinary Practice 2026
• Selling a Veterinary Specialty Hospital in 2026
• How to Prepare Your Veterinary Practice for a Sale or Exit (2026)
• How to Buy a Veterinary Practice in 2026 (Buyer’s Playbook)
• The lower middle market buyer mandate report
• Exit multiple: the 2026 operator’s guide

Georgia veterinary practice sale: 2026 outlook and key takeaways

Veterinary is one of the deepest consolidation pools in healthcare-adjacent services, and Georgia is a strong Sun Belt seat in it. Cumulative private-equity investment reached $51.6 billion over 2017 to 2023 with another $9.3 billion in early 2024 (American Economic Liberties Project), 15-plus national platforms compete alongside Mars permanent capital, and a structural seller wave is building as 61% of clinical-practice DVMs plan to cut clinical hours within five years (JAVMA 2024-2025). A Georgia hospital with four to eight doctors, wellness penetration past 12 to 15%, normalized production comp, a current premise permit and DEA registration, clean real-estate optionality, and non-competes drafted to the Restrictive Covenants Act can realistically reach the upper end of its 9.5x to 11.5x tier, with multi-site groups reaching 12x to 15x. The things that most often cost Georgia sellers money are an unprepared production-comp recut, outreach to stale buyer lists, drafting around a corporate-practice ban Georgia does not have, ignoring the antitrust look in specialty-dense metros, and accepting the first offer instead of running metro Atlanta as the competitive process it can be.

This guide reflects 2026 veterinary M&A conditions and CT Acquisitions direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. Georgia premise permitting under the Georgia State Board of Veterinary Medicine, non-veterinarian employment under O.C.G.A. 43-50-30(c), DEA registration transfer, Georgia non-compete standards under the Restrictive Covenants Act (O.C.G.A. 13-8-50 et seq.), the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions RFI, and Georgia tax provisions are all subject to change; confirm current requirements with qualified Georgia veterinary counsel before relying on them in a transaction.

Related sale guides for Georgia sellers

If you operate a different business in Georgia, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Georgia-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.

Other Georgia industry sale guides

• Sell a CPA / accounting firm in Georgia
• Sell a RIA / wealth management firm in Georgia
• Sell an insurance agency in Georgia
• Sell a managed IT / MSP business in Georgia
• Sell a Commercial HVAC business in Georgia
• Sell Your Georgia Business (state hub with all verticals)

Veterinary practice sales in other states

• Texas
• California
• Florida

Georgia veterinary practice sale: frequently asked questions